Publication Beamlines Strategic Pillar
(2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T.
(2015). Anti-hemagglutinin antibodies and methods of use. Patent Number: IL238684A0.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL320478A.
(2022). ANTIBODY EPITOPE. Patent Number: PT3311171T.
(2023). Novel tnf structure for use in therapy. Patent Number: PT3311168T.
(2015). ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE. Patent Number: AR093446A1.
(2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL298041B2.
(2015). Novel TNFa structure for use in therapy. Patent Number: GB201510758D0.
(2007). News and Views: Mining Environmental Problems at the Canadian Light Source. Synchrotron Radiation News 20(3) . 10.1080/08940880701401169. Materials
(2007). News and Views: Industrial Services and Solutions at the Canadian Light Source. Synchrotron Radiation News 20(4) . 10.1080/08940880701510811. Materials
(2010). Goldschmidt Abstracts 2010 – B. Geochimica et Cosmochimica Acta 74(12) , A38-A134. 10.1016/j.gca.2010.04.027. SM